Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging and Deep Phenotyping to Identify Predictors of AS Disease Activity and Progression

NCT07819344 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07819344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07819344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging and Deep Phenotyping to Identify Predictors of AS Disease Activity and Progression
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
March 30, 2031
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve diseases, calcification; heart